Title: | Reduced diffusing capacity for carbon monoxide predicts borderline pulmonary arterial pressure in patients with systemic sclerosis |
Authors: | Ninagawa, Keita Browse this author |
Kato, Masaru Browse this author →KAKEN DB |
Nakamura, Hiroyuki Browse this author |
Abe, Nobuya Browse this author |
Kono, Michihito Browse this author →KAKEN DB |
Fujieda, Yuichiro Browse this author →KAKEN DB |
Oku, Kenji Browse this author →KAKEN DB |
Yasuda, Shinsuke Browse this author →KAKEN DB |
Ohira, Hiroshi Browse this author →KAKEN DB |
Tsujino, Ichizo Browse this author →KAKEN DB |
Atsumi, Tatsuya Browse this author →KAKEN DB |
Keywords: | Pulmonary arterial hypertension |
Systemic sclerosis |
Screening |
FVC |
DLCO |
Issue Date: | Nov-2019 |
Publisher: | Springer |
Journal Title: | Rheumatology international |
Volume: | 39 |
Issue: | 11 |
Start Page: | 1883 |
End Page: | 1887 |
Publisher DOI: | 10.1007/s00296-019-04370-0 |
Abstract: | Early intervention in pulmonary arterial hypertension associated with systemic sclerosis (SSc) may improve its prognosis. We aimed to establish an algorithm to detect mean pulmonary artery pressure (mPAP) > 20 mmHg using non-invasive examinations in SSc patients by modifying the DETECT algorithm. This study included SSc patients who underwent right heart catheterization (RHC) in our hospital during 2010-2018. Following variables were assessed for performance to predict mPAP >= 25 mmHg or > 20 mmHg; anti-centromere or U1-RNP antibody, plasma BNP level, serum urate level, right axis deviation, forced vital capacity (FVC)/diffusing capacity for carbon monoxide (DLCO) ratio, and tricuspid regurgitation velocity. Of 58 patients enrolled in this study, 24 had mPAP of >= 25 mmHg and 9 had mPAP of 21-24 mmHg. Among variables tested, only FVC/DLCO elevated similarly in patients with mPAP of >= 25 mmHg (median 2.5) and those with mPAP of 21-24 mmHg (median 2.5) compared to those with mPAP of <= 20 mmHg (median 1.5). Given the particularly good correlation between DLCO and mPAP of > 20 mmHg, each variable was weighted according to its odds ratio and the total weighted score was calculated. The total weighted score exhibited a good predictive performance for mPAP of > 20 mmHg with its sensitivity of 87.5% and specificity of 92%. Among conventional risk factors for PAH, decreased DLCO may predict mPAP > 20 mmHg with priority in SSc patients. Weighting DLCO may improve the performance of screening algorithm for early SSc-PAH. |
Rights: | This is a post-peer-review, pre-copyedit version of an article published in Rheumatology international. The final authenticated version is available online at: http://dx.doi.org/10.1007/s00296-019-04370-0 |
Type: | article (author version) |
URI: | http://hdl.handle.net/2115/79648 |
Appears in Collections: | 医学院・医学研究院 (Graduate School of Medicine / Faculty of Medicine) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)
|